4. Segment Information and Concentrations

6 Months Ended

Dec. 31, 2013

Segment Reporting [Abstract]

Segment Information and Concentrations

4. Segment Information and Concentrations:

The Company views its operations as three segments: the manufacture and marketing of standard benchtop laboratory equipment for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors (ABenchtop Laboratory Equipment@), the manufacture and marketing of custom-made catalyst research instruments for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (ACatalyst Research Instruments@) and the marketing and production of bioprocessing systems for laboratory research in the biotechnology industry sold directly to customers and through distributors ("Bioprocessing Systems").

Segment information is reported as follows (foreign sales are principally to customers in Europe and Asia):

	Benchtop Laboratory Equipment		Catalyst Research Instruments		Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended December 31, 2013
Revenues	$	1,154,000	$	463,400	$	130,400		$	—		$	1,747,800
Foreign Sales		823,400		88,900		—			—			912,300
Income (Loss) from Opertions		119,800		2,100		64,600			(10,000	)		176,500
Assets		2,787,400		1,704,400		981,600			829,800			6,303,200
Long-Lived Asset Expenditures		10,100		—		6,000			—			16,100
Depreciation and Amortization		11,600		8,500		24,200			—			44,300
		Benchtop Laboratory Equipment		Catalyst Research Instruments		Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended December 31, 2012
Revenues	$	1,164,900	$	664,900	$	47,100		$	—		$	1,876,900
Foreign Sales		747,900		279,800		—			—			1,027,700
Income (Loss) from Operations		157,200		68,200		(30,900	)		—			194,500
Assets		2,485,700		1,695,400		963,100			915,800			6,060,000
Long-Lived Asset Expenditures		7,100		700		—			—			7,800
Depreciation and Amortization		11,500		9,200		24,000			—			44,700

Approximately 65% and 73% of net sales of benchtop laboratory equipment (43% and 46% of total net sales) for the three month periods ended December 31, 2013 and 2012, respectively, were derived from the Company's main product, the Vortex-Genie 2® mixer, excluding accessories.

Two customers accounted in the aggregate for approximately 25% and 24% of the net sales of the Benchtop Laboratory Equipment Operations and 17% and 15% of total revenues for the three months ended December 31, 2013, and 2012, respectively. Sales of catalyst research instruments generally comprise a few very large orders averaging at least $100,000 per order to a limited number of customers, who differ from order to order. Sales to three customers and four customers represented approximately 91% and 95% of the Catalyst Research Instrument Operations' net sales, respectively, and 24% and 34% of total revenues for the three months ended December 31, 2013 and 2012, respectively.

Benchtop Catalyst Corporate Laboratory Research Bioprocessing and Equipment Instruments Systems Other Consolidated

		Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Six months ended December 31, 2013
Revenues	$	2,223,700	$	803,100		$	157,100		$	—		$	3,183,900
Foreign Sales		1,444,200		162,400			2,000			—		$	1,608,600
Income (Loss) from Operations		238,100		(101,900	)		47,800			(10,500	)	$	173,500
Assets		2,787,400		1,704,400			981,600			829,800		$	6,303,200
Long-Lived Asset Expenditures		20,000		—			6,500			—		$	26,500
Depreciation and Amortization		22,600		17,600			48,300			—		$	88,500
		Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Six months ended December 31, 2012
Revenues	$	2,229,700	$	949,200		$	49,700		$	—		$	3,228,600
Foreign Sales		1,369,600		519,000			—			—			1,888,600
Income (Loss) from Operations		274,800		(66,100	)		(105,900	)		—			102,800
Assets		2,485,700		1,695,400			963,100			915,800			6,060,000
Long-Lived Asset Expenditures		9,200		18,100			—			—			27,300
Depreciation and Amortization		22,600		18,500			47,900			—			89,000

Approximately 66% and 68% of net sales of benchtop laboratory equipment (46% and 47% of total revenues) for the six month periods ended December 31, 2013 and 2012, respectively, were derived from the segment's main product, the Vortex- Genie 2® mixer, excluding accessories.

Two benchtop laboratory equipment customers, accounted in the aggregate for approximately 21% and 23% of the segments net sales for the six month periods ended December 31, 2013 and 2012, and 14% and 16%, of total revenues for the six month periods ended December 31, 2013 and 2012, respectively.

Sales of catalyst research instruments to six and four different customers in each of the six month periods, accounted for approximately 92% and 67% of the segments net sales and 23% and 20% of total revenues for the six month periods ended December 31, 2013 and 2012, respectively.